• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

SV Life Sciences

edit

SV Life Sciences is a venture capital adviser and manager that makes selected investments in entrepreneurs and management teams.

SV Life Sciences provides finance to businesses at all stages of development and across the human life sciences sector. These sectors range from biotechnology & pharmaceuticals to medical devices & instruments, to healthcare information technology and services. SV Life Sciences currently advises or manages five funds with capital commitments of approximately $1.5 billion which primarily invest amounts of between $1m and $40m in North America and Europe, but will consider innovative investments in other regions. Our team of 34 professionals has a diverse, complimentary set of skills and experience that allow us to tailor a team to work with almost any life sciences business.

Recent Milestones

edit

• 
  SV Life Sciences invested in Catabasis Pharmaceuticals. (2/6/13)
  Posted 2/6/13 at 8:32pm via fiercebiotech.com
• 
  SV Life Sciences invested in Ocular Therapeutix. (1/28/13)
  Posted 1/28/13 at 6:43pm via businesswire.com
• 
  SV Life Sciences invested in Bicycle Therapeutics. (12/10/12)
  Posted 12/11/12 at 5:39am via finsmes.com
• 
  SV Life Sciences invested in Health Essentials. (10/25/12)
  Posted 10/25/12 at 6:06pm via finsmes.com
• 
  SV Life Sciences invested in ReShape Medical. (10/23/12)
  Posted 10/25/12 at 6:28pm via dowjones.com
• 
  SV Life Sciences invested in Cibiem. (10/17/12)
  Posted 10/18/12 at 4:45am via finsmes.com
• 
  SV Life Sciences invested in Karus Therapeutics . (9/6/12)
  Posted 9/6/12 at 11:58pm via dowjones.com
• 
  SV Life Sciences invested in Sutro Biopharma. (5/8/12)
  Posted 5/8/12 at 5:57am via yahoo.com
• 
  SV Life Sciences invested in Adimab. (4/3/12)
  Posted 4/3/12 at 8:04pm via fiercebiotech.com
• 
  SV Life Sciences invested in AlloCure. (4/2/12)
  Posted 4/2/12 at 5:19pm via masshightech.com
• 
  SV Life Sciences invested in WellNow Urgent Care. (2/15/12)
  Posted 2/15/12 at 7:38pm via finsmes.com
• 
  SV Life Sciences invested in CSA Medical. (12/15/11)
  Posted 12/15/11 at 7:19pm via finsmes.com
• 
  SV Life Sciences invested in Catabasis Pharmaceuticals. (12/13/11)
  Posted 12/13/11 at 7:37pm via catabasispharma.com
• 
  SV Life Sciences invested in TopiVert. (12/6/11)
  Posted 12/6/11 at 11:10pm via finsmes.com
• 
  SV Life Sciences invested in AcuFocus. (11/29/11)
  Posted 11/29/11 at 9:52pm via finsmes.com
• 
  SV Life Sciences invested in Rempex Pharmaceuticals. (11/9/11)
  Posted 11/9/11 at 9:22pm via rempexpharma.com

Investments

Videos

Sources

1. SV Life Sciences flush with venture cash, bullish on exit deals Read more: SV Life Sciences flush with venture cash, bullish on exit deals (fiercebiotech.com) [edit]
2. Catabasis raises $9M for PhII-ready drug development program (fiercebiotech.com) [edit]
3. Ocular Therapeutix, Inc. Closes on $23.8 Million Series D Extension (businesswire.com) [edit]
4. Bicycle Therapeutics Raises £3.75M in Funding (finsmes.com) [edit]
5. Health Essentials Receives Growth Capital Investment (finsmes.com) [edit]
6. Obesity-Device Maker ReShape Medical Raises More Than $15M of $20M Series C (pevc.dowjones.com) [edit]
7. Cibiem Raises $10M in Series A Financing (finsmes.com) [edit]
8. Karus Thera Picks Up $7.6M to Develop Two Preclinical Compounds (pevc.dowjones.com) [edit]
9. Sutro Closes $16.5 Million Second Tranche of Series C Financing (finance.yahoo.com) [edit]
10. Google contributes to $14M round for fast-growing Adimab (fiercebiotech.com) [edit]
11. AlloCure raises $25M round for kidney disease trial (masshightech.com) [edit]
12. WellNow Urgent Care Launches with $35M (finsmes.com) [edit]
13. CSA Medical Raises $20.5M in Series B Funding (finsmes.com) [edit]
14. Catabasis Pharmaceuticals Announces $8 Million Series A Extension Financing (catabasispharma.com) [edit]
15. TopiVert Raises £8M (finsmes.com) [edit]
16. AcuFocus Closes $65M Financing (finsmes.com) [edit]
17. Rempex Announces Series B Financing of up to $67.5 Million (rempexpharma.com) [edit]
18. Imagen Biotech Secures Up to $40 Million to Advance Ophthalmology Therapies (businesswire.com) [edit]
19. CardioKinetix Raises $44M in Series E Financing (finsmes.com) [edit]
20. Affinium Pharmaceuticals Announces the Closing of $15 Million Financing (afnm.com) [edit]
21. KalVista Pharmaceuticals Launched With £8 Million in Series A Funding to Develop Novel Class of Drugs for Diabetic Macular Edema (prnewswire.com) [edit]
22. Entellus Medical Completes $35M Funding Round (finsmes.com) [edit]
23. Vantia Therapeutics Raises £4 Million to Fund Clinical Development of its Lead Compounds (vantiatherapeutics.com) [edit]
24. Cyterix Pharmaceutics Raises $9.2M in Series A Financing (finsmes.com) [edit]
25. Delenex Therapeutics Raises $19.3M (finsmes.com) [edit]
26. Arsanis closes Series A financing for $10 million (news-medical.net) [edit]
27. CardioFocus, Inc. Raises $30.6 Million in Private Financing (finance.yahoo.com) [edit]
28. PanOptica Raises $30m in Series A Financing (finsmes.com) [edit]
29. Sutro Biopharma Secures $36.5M in Series C Financing (finsmes.com) [edit]
30. Delenex Therapeutics Closes CHF13.5M Series A Venture Capital Financing Round (finsmes.com) [edit]
31. Convergence Pharmaceuticals Raises $35.4M in Series A Financing (finsmes.com) [edit]
32. Good Start Genetics, Inc. Raises $18 Million to Develop and Launch Sequencing‐Based Pre‐Pregnancy Genetic Screening Test (goodstartgenetics.com) [edit]
33. Altura Medical, Inc.: Series A $20M (onbiovc.com) [edit]
34. AqueSys, Inc.: Series C $35M (onbiovc.com) [edit]
35. Logical Therapeutics closes $16.9M round for NSAID program (fiercebiotech.com) [edit]
36. Catabasis lands $39M Series A for diabetes programs (fiercebiotech.com) [edit]
37. Juvaris BioTherapeutics, Inc.: Series B $12.5M (onbiovc.com) [edit]
38. Juvaris BioTherapeutics Completes Second Close on $25M Series B Financing (finsmes.com) [edit]
39. Adimab, Inc.: Series D $8.2M (onbiovc.com) [edit]
40. TransEnterix, Inc.: Series B $55M (onbiovc.com) [edit]
41. Ophthotech nabs $30M round to fund AMD trial (fiercebiotech.com) [edit]
42. Oxagen rounds up $26.7M in VC (fiercebiotech.com) [edit]
43. MorningStar (news.morningstar.com) [edit]
44. ValenTx, Inc.: Series B $20.3M (onbiovc.com) [edit]
45. Lux Biosciences scores $50M Series B for eye cure (venturebeat.com) [edit]
46. Cadent Closes $15 Million Funding Round (freshnews.com) [edit]
47. I-Therapeutix, Inc.: Series C $15M (onbiovc.com) [edit]
48. Sadra Medical, Inc.: Series C $30M (onbiovc.com) [edit]
49. Sutro Biopharma lands $15M with protein production (bizjournals.com) [edit]
50. NKT Therapeutics launches with $8M (bizjournals.com) [edit]
51. LensX Lasers nabs $22M for eye surgery lasers (venturebeat.com) [edit]
52. ReShape beefs up with $20M to bust fat (deals.venturebeat.com) [edit]
53. Adimab, Inc. Announces Series C Financing (adimab.com) [edit]
54. ESBATech rounds up $22M in second round (fiercebiotech.com) [edit]
55. Capital Funding Report [edit]
56. Split Rock Partners (splitrock.com) [edit]
57. Fundamental Applied Biology, Inc. Completes $21 Million Series B Financing Daniel S. Gold, PhD, Joins as Chief Executive Officer (sutrobio.com) [edit]
58. Fundamental Applied Biology raises $21M for making “cell-free” proteins (deals.venturebeat.com) [edit]
59. EDGAR [edit]
60. SEC D (sec.gov) [edit]
61. ReShape Medical Secures $3 Million in Series A Financing (researchviews.com) [edit]
62. Split Rock Partners (splitrock.com) [edit]
63. NeoVista, a co. targeting age-related macular degeneration, raises $41M (deals.venturebeat.com) [edit]
64. Neurotechâ„¢, Inc. Completes $35 Million Private Equity Financing (neurotechusa.com) [edit]
65. Sadra Medical Raises $19 Million In Series B Financing (biospace.com) [edit]
66. NeoVista, a radiation treatment device maker, to raise $26M (deals.venturebeat.com) [edit]
67. ESBATech Closes USD 41M Series B Venture Financing (esbatech.com) [edit]
68. Split Rock Partners (splitrock.com) [edit]
69. EDGAR [edit]
70. Mpex Pharmaceuticals Closes $32 Million Series B Financing (mpexpharma.com) [edit]